Parkinson's disease (PD) is a progressive, neurodegenerative disorder that primarily affects motor function, due to the loss of dopamine-producing cells in the substantia nigra. Understanding its pathophysiology, clinical presentation, diagnosis, and management is crucial for medical professionals.
The hallmark of PD is the degeneration of dopamine-producing neurons within the substantia nigra, leading to a decrease in striatal dopamine levels. This imbalance affects the normal functioning of the basal ganglia circuitry, resulting in the characteristic motor symptoms of PD.
The cardinal symptoms of PD include resting tremor, rigidity, bradykinesia, and postural instability. Non-motor symptoms such as cognitive impairment, mood disorders, sleep disturbances, and autonomic dysfunction can also occur, often preceding motor symptoms by years.
Diagnosis of PD is primarily clinical, based on the presence of characteristic motor symptoms and response to dopaminergic therapy. Neuroimaging techniques such as DaTscan can support the diagnosis but are not routinely used due to their high cost and limited availability.
Management of PD is symptomatic, with the primary aim to improve quality of life. Pharmacological treatment mainly involves dopamine replacement therapies. Non-pharmacological interventions include physical therapy, occupational therapy, and in advanced cases, deep brain stimulation.
PD is a complex neurodegenerative disorder with a multifaceted clinical presentation. A comprehensive understanding of its pathophysiology, clinical features, diagnosis, and management strategies is essential for optimal patient care. As medical professionals, we must stay abreast of the latest research developments to provide the best possible care to our patients with PD.
1.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
2.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
3.
Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Long-Acting Interferon Therapy Approved for ET
1.
Molecular Network Mapping in Hematologic Disease
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
4.
Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange
5.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Common side effects of cancer treatment and how they are managed
3.
Clinical Excellence in Hematology
4.
Best Practices in Hematology
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation